Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Huhn

Showing results (361-370 of 380) with videos related to

Pageof 38
Sort By:
British Journal of Cancer|November 27, 1999
Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphomaI G Schmidt-Wolf, S Finke, B Trojaneck, et al.
Bone Marrow Transplantation|June 19, 1998
Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CMLT Fischer, A Neubauer, J Mohm, et al.
AIDS Research and Therapy|August 30, 2019
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD studyGregory D Huhn, Joseph J Eron, Pierre-Marie Girard, et al.
Plos One|February 14, 2020
Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCVSonia Vibhakar Patel, Dushyantha T Jayaweera, Keri N Althoff, et al.
Blood|October 24, 2002
High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopeniaRichard D Huhn, Patrick F Fogarty, Ryotaro Nakamura, et al.
Science (New York, N.Y.)|March 26, 2011
CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humansGregory L Beatty, Elena G Chiorean, Matthew P Fishman, et al.
American Journal of Therapeutics|March 31, 1999
Effect of montelukast on single-dose theophylline pharmacokineticsK Malmstrom, J Schwartz, T F Reiss, et al.
Leukemia Research|June 18, 2014
Combination anti-CD137 and anti-CD40 antibody therapy in murine myc-driven hematological cancersJennifer A Westwood, Geoffrey M Matthews, Jake Shortt, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2019
Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarateKristina M Brooks, Mustafa E Ibrahim, Jose R Castillo-Mancilla, et al.
Human Gene Therapy|February 15, 2001
Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trialB Wittig, A Märten, T Dorbic, et al.
Pageof 38

Showing results (361-370 of 380) with videos related to

Sort By:
Pageof 38
British Journal of Cancer|November 27, 1999
Phase I clinical study applying autologous immunological effector cells transfected with the interleukin-2 gene in patients with metastatic renal cancer, colorectal cancer and lymphomaI G Schmidt-Wolf, S Finke, B Trojaneck, et al.
Bone Marrow Transplantation|June 19, 1998
Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CMLT Fischer, A Neubauer, J Mohm, et al.
AIDS Research and Therapy|August 30, 2019
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-experienced, virologically suppressed patients with HIV-1: subgroup analyses of the phase 3 EMERALD studyGregory D Huhn, Joseph J Eron, Pierre-Marie Girard, et al.
Plos One|February 14, 2020
Real-world efficacy of direct acting antiviral therapies in patients with HIV/HCVSonia Vibhakar Patel, Dushyantha T Jayaweera, Keri N Althoff, et al.
Blood|October 24, 2002
High-dose cyclophosphamide with autologous lymphocyte-depleted peripheral blood stem cell (PBSC) support for treatment of refractory chronic autoimmune thrombocytopeniaRichard D Huhn, Patrick F Fogarty, Ryotaro Nakamura, et al.
Science (New York, N.Y.)|March 26, 2011
CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humansGregory L Beatty, Elena G Chiorean, Matthew P Fishman, et al.
American Journal of Therapeutics|March 31, 1999
Effect of montelukast on single-dose theophylline pharmacokineticsK Malmstrom, J Schwartz, T F Reiss, et al.
Leukemia Research|June 18, 2014
Combination anti-CD137 and anti-CD40 antibody therapy in murine myc-driven hematological cancersJennifer A Westwood, Geoffrey M Matthews, Jake Shortt, et al.
The Journal of Antimicrobial Chemotherapy|May 17, 2019
Pharmacokinetics of tenofovir monoester and association with intracellular tenofovir diphosphate following single-dose tenofovir disoproxil fumarateKristina M Brooks, Mustafa E Ibrahim, Jose R Castillo-Mancilla, et al.
Human Gene Therapy|February 15, 2001
Therapeutic vaccination against metastatic carcinoma by expression-modulated and immunomodified autologous tumor cells: a first clinical phase I/II trialB Wittig, A Märten, T Dorbic, et al.
Pageof 38